Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

Table 2 Summary of suPAR/creatinine data for patients and controls

	Healthy Controls	Chronic Pancreatitis	Ductal Carcinoma
Number of cases	104	52	94
Mean Age (SD)	53 (19)	50 (12)	60 (10)
Males/females	56/48	37/15	44/50
suPAR/creatinine median (25^th-75^th percentile)	0 (0-0.5)	2.7 (0.9-4.7)	9.8 (5.3-20.7)
Comparison with controls median*	-	p < 0.0001	p < 0.0001
Elevated suPAR/creatinine°	4.8%	9.6% (p = 0.32)	53.2% (p < 0.0001)

°Value beyond 9.1 ng/mg (healthy donors' 95^th percentile) was used as a threshold, comparison with proportions of healthy controls by fisher's exact test.
* Mann-Whitney test

ISSN: 1471-2407